questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines virales
Protéines virales structurales
Protéines de l'enveloppe virale
Protéines de la matrice virale
Protéines de la matrice virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de la matrice virale : Questions médicales les plus fréquentes",
"headline": "Protéines de la matrice virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de la matrice virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-05",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de la matrice virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de l'enveloppe virale",
"url": "https://questionsmedicales.fr/mesh/D014759",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de l'enveloppe virale",
"code": {
"@type": "MedicalCode",
"code": "D014759",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.964.970.880"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéines M des coronavirus",
"alternateName": "Coronavirus M Proteins",
"url": "https://questionsmedicales.fr/mesh/D000086862",
"about": {
"@type": "MedicalCondition",
"name": "Protéines M des coronavirus",
"code": {
"@type": "MedicalCode",
"code": "D000086862",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.964.970.880.940.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines de la matrice virale",
"alternateName": "Viral Matrix Proteins",
"code": {
"@type": "MedicalCode",
"code": "D014763",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhiqiang Duan",
"url": "https://questionsmedicales.fr/author/Zhiqiang%20Duan",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Animal Genetics, Breeding and Reproduction in the Plateau Mountainous Region, Ministry of Education, Guizhou University, Guiyang, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Monica L Husby",
"url": "https://questionsmedicales.fr/author/Monica%20L%20Husby",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry & Molecular Pharmacology, Purdue University, West Lafayette, IN, USA."
}
},
{
"@type": "Person",
"name": "Elsje Pienaar",
"url": "https://questionsmedicales.fr/author/Elsje%20Pienaar",
"affiliation": {
"@type": "Organization",
"name": "Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D), Purdue University, West Lafayette, West Lafayette, IN, USA."
}
},
{
"@type": "Person",
"name": "Robert V Stahelin",
"url": "https://questionsmedicales.fr/author/Robert%20V%20Stahelin",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry & Molecular Pharmacology, Purdue University, West Lafayette, IN, USA."
}
},
{
"@type": "Person",
"name": "Hong Tang",
"url": "https://questionsmedicales.fr/author/Hong%20Tang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Animal Genetics, Breeding and Reproduction in the Plateau Mountainous Region, Ministry of Education, Guizhou University, Guiyang, People's Republic of China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Memory B cell responses induced by pneumococcal conjugate vaccine schedules with fewer doses: analysis of a randomised-controlled trial in Viet Nam.",
"datePublished": "2024-08-14",
"url": "https://questionsmedicales.fr/article/39138203",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-024-51413-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Did the change of the vaccination schedule effect pneumococcal conjugate vaccination compliance and adherence of premature and mature born infants in Germany? Answers from a claims database analysis.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37263871",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.vaccine.2023.05.045"
}
},
{
"@type": "ScholarlyArticle",
"name": "Summary of New Guidance on Selected Immunizations.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36343700",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nwh.2022.10.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Policies for the immunization against serogroup B meningococcus for adolescents immunized during the first two years of life: A mini review.",
"datePublished": "2024-09-12",
"url": "https://questionsmedicales.fr/article/39263919",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2024.2396220"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disparate kinetics in immune response of two different",
"datePublished": "2024-04-30",
"url": "https://questionsmedicales.fr/article/38687024",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2024.2342630"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines virales",
"item": "https://questionsmedicales.fr/mesh/D014764"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines virales structurales",
"item": "https://questionsmedicales.fr/mesh/D015678"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines de l'enveloppe virale",
"item": "https://questionsmedicales.fr/mesh/D014759"
},
{
"@type": "ListItem",
"position": 7,
"name": "Protéines de la matrice virale",
"item": "https://questionsmedicales.fr/mesh/D014763"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de la matrice virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de la matrice virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines de la matrice virale",
"description": "Comment identifier les protéines de la matrice virale ?\nQuels tests sont utilisés pour détecter ces protéines ?\nLes protéines de la matrice peuvent-elles être détectées dans le sang ?\nQuel rôle jouent les anticorps dans le diagnostic ?\nPeut-on utiliser la biopsie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014763?mesh_terms=Immunization+Schedule&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines de la matrice virale",
"description": "Quels symptômes sont associés aux infections virales ?\nLes protéines de la matrice causent-elles des symptômes spécifiques ?\nComment les symptômes varient-ils selon le virus ?\nLes symptômes peuvent-ils apparaître rapidement ?\nY a-t-il des symptômes chroniques liés aux protéines virales ?",
"url": "https://questionsmedicales.fr/mesh/D014763?mesh_terms=Immunization+Schedule&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines de la matrice virale",
"description": "Comment prévenir les infections virales liées aux protéines ?\nLes mesures d'hygiène sont-elles efficaces ?\nLes voyages peuvent-ils augmenter le risque d'infection ?\nLes masques aident-ils à prévenir les infections virales ?\nLes campagnes de vaccination sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D014763?mesh_terms=Immunization+Schedule&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines de la matrice virale",
"description": "Quels traitements ciblent les protéines de la matrice virale ?\nLes vaccins agissent-ils sur ces protéines ?\nComment les traitements immunomodulateurs aident-ils ?\nLes traitements sont-ils efficaces contre tous les virus ?\nY a-t-il des effets secondaires des traitements antiviraux ?",
"url": "https://questionsmedicales.fr/mesh/D014763?mesh_terms=Immunization+Schedule&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines de la matrice virale",
"description": "Quelles complications peuvent survenir avec les infections virales ?\nLes protéines de la matrice peuvent-elles causer des complications ?\nComment les complications sont-elles gérées ?\nLes complications sont-elles prévisibles ?\nLes complications peuvent-elles être mortelles ?",
"url": "https://questionsmedicales.fr/mesh/D014763?mesh_terms=Immunization+Schedule&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines de la matrice virale",
"description": "Quels sont les principaux facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes conditions de santé préexistantes sont-elles un facteur ?\nL'âge joue-t-il un rôle dans le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014763?mesh_terms=Immunization+Schedule&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les protéines de la matrice virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par des techniques comme l'immunoblotting et la PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter ces protéines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et les tests de culture virale sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les protéines de la matrice peuvent-elles être détectées dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être détectées dans le sérum des patients infectés."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les anticorps dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticorps spécifiques peuvent indiquer une infection par des protéines virales."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la biopsie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une biopsie peut aider à détecter des protéines virales dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux infections virales ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, fatigue, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les protéines de la matrice causent-elles des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent induire des réponses immunitaires, entraînant divers symptômes."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon le virus ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chaque virus a un profil symptomatique unique, influencé par ses protéines."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils apparaître rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus provoquent des symptômes aigus en quelques jours."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes chroniques liés aux protéines virales ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent entraîner des symptômes persistants ou chroniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales liées aux protéines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination et l'hygiène personnelle sont essentielles pour la prévention."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le lavage des mains et l'utilisation de désinfectants réduisent les infections."
}
},
{
"@type": "Question",
"name": "Les voyages peuvent-ils augmenter le risque d'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à risque peut exposer à des virus spécifiques."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir les infections virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virus par voie respiratoire."
}
},
{
"@type": "Question",
"name": "Les campagnes de vaccination sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent significativement l'incidence des infections virales."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les protéines de la matrice virale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux spécifiques peuvent inhiber la fonction des protéines virales."
}
},
{
"@type": "Question",
"name": "Les vaccins agissent-ils sur ces protéines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains vaccins stimulent la réponse immunitaire contre ces protéines."
}
},
{
"@type": "Question",
"name": "Comment les traitements immunomodulateurs aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils renforcent la réponse immunitaire contre les protéines virales et l'infection."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces contre tous les virus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'efficacité dépend du type de virus et de ses protéines spécifiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements antiviraux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antiviraux peuvent provoquer des effets secondaires variés chez les patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les infections virales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent pneumonie, encéphalite et défaillance organique."
}
},
{
"@type": "Question",
"name": "Les protéines de la matrice peuvent-elles causer des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent contribuer à la virulence et à la gravité des infections."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont gérées par des soins symptomatiques et des traitements spécifiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées selon le virus et le patient."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être mortelles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent entraîner des complications fatales."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'immunodépression et l'exposition à des virus."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions endémiques expose à des virus spécifiques."
}
},
{
"@type": "Question",
"name": "Les conditions de santé préexistantes sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme le diabète ou l'asthme augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus vulnérables."
}
}
]
}
]
}
The use of pneumococcal conjugate vaccine (PCV) schedules with fewer doses are being considered to reduce costs and improve access, particularly in low- and middle-income countries. While several stud...
In August 2015, the German Standing Committee on Vaccination (STIKO) changed the pneumococcal conjugate vaccination (PCV) schedule for mature infants from a 3+1 to a 2+1scheme. For premature infants, ...
Retrospective claims data analyses were conducted using a comprehensive research database. The study population consisted of all mature and premature infants born in 2013, 2016, or 2018 with an indivi...
After follow-up of 24 months, rates of premature and mature infants receiving ≥1PCV and HEXA vaccination steadily increased since the change of STIKO's recommendation. However, in 2018 (2016/2013), on...
There is no proven evidence that the reduced PCV schedule for mature infants induced a higher acceptance of vaccination. The rate of unvaccinated infants remained at a considerable level and vaccinati...
In 2022, the Centers for Disease Control and Prevention (CDC) updated its Adult Immunization Schedule Recommendations for Ages 19 Years or Older to provide the most current evidence-based recommendati...
Two vaccines are available to prevent serogroup B meningococcal disease, i.e. the four-component meningococcal serogroup B vaccine (4CMenB) and the bivalent-factor-H-binding-protein meningococcal sero...
Since the introduction of...
Childhood immunization is a cost-effective way to protect individuals against communicable diseases. However, although there is a large literature on childhood immunization in Indonesia, there is a pa...
In this paper, using seven waves of data from the nationally representative Indonesia Demographic and Health Surveys (DHS) covering the period 1991- 2017, we empirically analyse the socio-economic and...
Our findings show that parental education and use of healthcare services are strong predictors of full immunization and age-appropriate vaccinations. This study also finds evidence of spatial heteroge...
Our analysis finds that despite an improvement in the timing of vaccinations over the last two decades, a significant proportion of children continue to receive their measles and DTwP vaccinations age...
Vaccination is the best mode of protection against tick-borne encephalitis (TBE) and its sequelae. The duration of protection and the optimal interval of repeat booster doses are still debated. The cu...
This phase IV, open-label, mono-centric extension study enrolled adults who had received (at ≥ 12 years of age) primary vaccination with one of three randomly assigned TBE vaccine schedules (rapid [gr...
In total, 194 participants were enrolled and included in the per-protocol set; 188 completed the study. The percentage of participants with an NT titer ≥ 10 was 100% in group R and 99.0% in group A at...
This study showed neutralizing antibody persistence for at least 15 years after a first booster dose of the Encepur Adults TBE vaccine in all age groups evaluated, regardless of which primary vaccinat...
The first year of the Coronavirus disease (COVID-19) pandemic registered the highest number of children under the age of one year who did not receive basic vaccines since 2009. The pronounced rise in ...
In Australian remote communities, First Nations children with otitis media (OM)-related hearing loss are disproportionately at risk of developmental delay and poor school performance, compared to thos...
In 2 sequential parallel, open-label, randomised controlled trials (the PREVIX trials), eligible infants were first allocated 1:1:1 at age 28 to 38 days to standard or mixed PCV schedules, then at age...
In this study, we observed a high prevalence and persistence of moderate (disabling) hearing loss throughout early childhood. We found a lower prevalence of moderate hearing loss and correspondingly h...
ClinicalTrials.gov NCT01735084 and NCT01174849....
The American Academy of Pediatrics recommends birth doses of vitamin K, erythromycin ointment, and the hepatitis B vaccine, but the relationship between birth medication administration and childhood i...
A retrospective chart review was completed for all term and late preterm infants born at Brooke Army Medical Center, San Antonio, TX, from January 1, 2016, to December 31, 2019. The electronic medical...
Seven thousand one hundred and forty infants were included; 99.3% received vitamin K, 98.8% received erythromycin ointment, and 93.8% received the hepatitis B vaccine. Refusal of the erythromycin oint...
Refusal of the hepatitis B vaccine in the nursery is associated with a risk of being under-immunized in childhood. Obstetric and pediatric providers should be aware of this association for appropriate...